CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS

Invasive pneumococcal infection is the most frequent cause of death in patients with immunodeficiences. The antibiotics used previously for prevention purposes are not efficient enough due to the developing antibiotic resistance. Polysaccharide pneumococcal vaccines create short-lived immunity. The...

Full description

Saved in:
Bibliographic Details
Main Authors: A.A. Tarasova, M.P. Kostinov
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2010-09-01
Series:Педиатрическая фармакология
Online Access:https://www.pedpharma.ru/jour/article/view/1091
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849244167915438080
author A.A. Tarasova
M.P. Kostinov
author_facet A.A. Tarasova
M.P. Kostinov
author_sort A.A. Tarasova
collection DOAJ
description Invasive pneumococcal infection is the most frequent cause of death in patients with immunodeficiences. The antibiotics used previously for prevention purposes are not efficient enough due to the developing antibiotic resistance. Polysaccharide pneumococcal vaccines create short-lived immunity. The overview summarizes the experience of applying conjugated pneumococcal vaccines in patients with primary immunodeficiences, HIV infection, oncological and rheumatic diseases. Key words: pneumococcal infection, pneumococcal conjugated vaccines, children, immunosuppression. (Pediatric Pharmacology. – 2010; 7(5):18-23)
format Article
id doaj-art-6b4574ad95494365883c8a83b87e38eb
institution Kabale University
issn 1727-5776
2500-3089
language Russian
publishDate 2010-09-01
publisher Union of pediatricians of Russia
record_format Article
series Педиатрическая фармакология
spelling doaj-art-6b4574ad95494365883c8a83b87e38eb2025-08-20T03:59:16ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892010-09-017518231086CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTSA.A. Tarasova0M.P. Kostinov1Nizhny Gorod Regional Children’s Clinical HospitalI.I. Mechnikov’s Research Institute for Vaccines and Sera at the Russia’s Academy of Medical Sciences, MoscowInvasive pneumococcal infection is the most frequent cause of death in patients with immunodeficiences. The antibiotics used previously for prevention purposes are not efficient enough due to the developing antibiotic resistance. Polysaccharide pneumococcal vaccines create short-lived immunity. The overview summarizes the experience of applying conjugated pneumococcal vaccines in patients with primary immunodeficiences, HIV infection, oncological and rheumatic diseases. Key words: pneumococcal infection, pneumococcal conjugated vaccines, children, immunosuppression. (Pediatric Pharmacology. – 2010; 7(5):18-23)https://www.pedpharma.ru/jour/article/view/1091
spellingShingle A.A. Tarasova
M.P. Kostinov
CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
Педиатрическая фармакология
title CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
title_full CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
title_fullStr CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
title_full_unstemmed CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
title_short CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
title_sort clinical and immunological effect of pneumococcal conjugated vaccines in immunocompromised patients
url https://www.pedpharma.ru/jour/article/view/1091
work_keys_str_mv AT aatarasova clinicalandimmunologicaleffectofpneumococcalconjugatedvaccinesinimmunocompromisedpatients
AT mpkostinov clinicalandimmunologicaleffectofpneumococcalconjugatedvaccinesinimmunocompromisedpatients